Form 8-K - Current report:
SEC Accession No. 0001493152-18-010451
Filing Date
2018-07-25
Accepted
2018-07-25 15:01:09
Documents
1
Period of Report
2018-07-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 39695
  Complete submission text file 0001493152-18-010451.txt   41063
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51353 | Film No.: 18968583
SIC: 7389 Services-Business Services, NEC